Study shows heart failure survivors at greater risk for cancer

June 25, 2013

Heart failure patients are surviving more often with the heart condition but they are increasingly more likely to be diagnosed with cancer, a trend that could be attributed to increased surveillance, side effects of treatments, or other causes, according to a study published online today in the Journal of the American College of Cardiology.

" patients are not only at an increased risk for developing cancer, but the occurrence of cancer increases mortality in these patients," explained Dr. Veronique Roger, MD, director of the Mayo Clinic Center for the Science of and co-author of the study. "These findings underscore the importance of cancer surveillance in the management of heart failure patients."

Researchers conducted the study using medical records from the Rochester Epidemiology Project, which links the inpatient and outpatient records from all providers used by the population of Olmsted County, Minn. The study included 596 paired with the same number of similar healthy subjects.

The study looked at two 11-year time periods. Patients diagnosed with heart failure between 1979 and 1990 had a 48 percent increased risk of cancer, while patients diagnosed between 1991 and 2002 had an 86 percent increased risk. Roger and colleagues suggest several possible causes for the increased risk of cancer in , including side effects of cardiovascular treatments, or stress from illness or other mechanisms associated with the physiology of heart failure such as inflammation.

Investigators stress the importance of the findings in the treatment and management of heart failure, concluding patients should be monitored closely for signs of cancer.

"These findings also illustrate the importance of multi-morbidity among patients living with and support the concept of providing holistic rather than disease-based care," the authors said.

Explore further: Heart failure patients may be at higher risk for cancer: study

Related Stories

Drug may improve outcomes after heart attack

March 12, 2013

The prescription drug eplerenone appears to reduce the risk of cardiovascular mortality and heart failure after a heart attack by more than one-third, according to research presented today at the American College of Cardiology's ...

Recommended for you

Artificial heart design features porous plastic foam

October 2, 2015

Artificial hearts with multiple moving parts increase the chance of failure; scientists have worked up a device which is a single piece. No less interesting is the material they used; the team is taking a page out of soft ...

What powers the pumping heart?

September 25, 2015

Researchers at the Ted Rogers Centre for Heart Research have uncovered a treasure trove of proteins, which hold answers about how our heart pumps—a phenomenon known as contractility.

Sticky gel helps stem cells heal rat hearts

September 24, 2015

A sticky, protein-rich gel created by Johns Hopkins researchers appears to help stem cells stay on or in rat hearts and restore their metabolism after transplantation, improving cardiac function after simulated heart attacks, ...


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.